We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

161 hedge funds and large institutions have $623M invested in Coherus Oncology in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.54% more ownership

Funds ownership: 99.55% → 101.09% (+1.5%)

9% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 55

6% less call options, than puts

Call options by funds: $1.18M | Put options by funds: $1.26M

7% less funds holding

Funds holding: 174 → 161 (-13)

16% less capital invested

Capital invested by funds: $744M → $623M (-$121M)

39% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 31

Holders
161
Holders Change
-13
Holders Change %
-7.47%
% of All Funds
2.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
60
Reduced
55
Closed
31
Calls
$1.18M
Puts
$1.26M
Net Calls
-$81K
Net Calls Change
+$594K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$12.9M
2
Citadel Advisors
Citadel Advisors
Florida
+$8.65M
3
BlackRock
BlackRock
New York
+$8.44M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.52M
5
JP Morgan Chase
JP Morgan Chase
New York
+$2.92M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$16M
2
TLP
Tri Locum Partners
New York
-$6.12M
3
TCM
Tang Capital Management
California
-$4.88M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$3.88M
5
Deutsche Bank
Deutsche Bank
Germany
-$2.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ensign Peak Advisors
176
Ensign Peak Advisors
Utah
– -$207K -21,490 Closed
DTL
177
Dynamic Technology Lab
Singapore
– -$197K -20,500 Closed
CCIA
178
Campbell & Co Investment Adviser
Maryland
– -$192K -19,934 Closed
PHK
179
Point72 Hong Kong
Hong Kong
– -$174K -18,108 Closed
ZCM
180
Zebra Capital Management
Connecticut
– -$122K -12,707 Closed
EGM
181
Engineers Gate Manager
New York
– -$115K -11,915 Closed
Verition Fund Management
182
Verition Fund Management
Connecticut
– -$103K -10,671 Closed
TSW
183
Thompson Siegel & Walmsley
Virginia
– -$97K -10,070 Closed
Parallax Volatility Advisers
184
Parallax Volatility Advisers
California
– -$70K -7,298 Closed
Federated Hermes
185
Federated Hermes
Pennsylvania
– -$41K -4,223 Closed
DFCM
186
Dark Forest Capital Management
Puerto Rico
– -$11K -1,129 Closed
EIP
187
Ellis Investment Partners
Pennsylvania
– -$6K -700 Closed
MAM
188
Meeder Asset Management
Ohio
– -$2K -199 Closed
AF
189
Allworth Financial
California
– -$1K -75 Closed
MPWT
190
MassMutual Private Wealth & Trust
Connecticut
– -$1K -70 Closed
ACM
191
Absolute Capital Management
Pennsylvania
– -$252 -27 Closed
4 5 6 7
8

CHRS Hedge Fund Activity: Q4 2022 in Review

161 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q4 2022, worth a combined $623M — down 16% from $744M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of CHRS and 19 opened new positions — a net loss of 12 holders — while 55 trimmed existing stakes and 60 added.

The largest buyer was State Street, adding an estimated $12.9M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $16M sold.

  • 161 institutional investors held Coherus Oncology (CHRS) as of Q4 2022, down from 174 in Q3 2022.
  • Funds reported $623M of Coherus Oncology stock for Q4 2022, down 16% quarter-over-quarter.
  • 19 funds opened new Coherus Oncology positions in Q4 2022 and 31 closed out, a net change of -12 holders.
  • The largest Coherus Oncology buyer in Q4 2022 was State Street, an estimated $12.9M added.
  • The largest Coherus Oncology seller in Q4 2022 was Perceptive Advisors, an estimated $16M sold.

Based on aggregated 13F filings for Q4 2022.